ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

PLRX Pliant Therapeutics Inc

13.79
-0.19 (-1.36%)
取引時間後
最終更新日: 06:44:53
15分遅延
名称 銘柄コード 市場 種別
Pliant Therapeutics Inc PLRX NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.19 -1.36% 13.79 06:44:53
始値 安値 高値 終値 前日終値
14.09 13.71 14.33 13.79 13.98
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0705:27EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/0705:11EDGAR2Form 8-K - Current report
2024/5/0705:05GLOBEPliant Therapeutics Provides Corporate Update and Reports..
2024/5/0619:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/0121:00GLOBEPliant Therapeutics to Participate in Upcoming Investor..
2024/4/0221:00GLOBEPliant Therapeutics to Participate in Upcoming Investor..
2024/3/2723:23GLOBEPliant Therapeutics Announces Upcoming Presentations at the..
2024/3/1220:30GLOBEPliant Therapeutics Announces Accelerated Bexotegrast..
2024/2/2806:20EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/2/2806:06EDGAR2Form 8-K - Current report
2024/2/2806:03GLOBEPliant Therapeutics Provides Corporate Update and Reports..
2024/2/2622:00GLOBEPliant Therapeutics to Participate in Upcoming Investor..
2024/2/1510:55EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/2/1422:52EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/0722:00GLOBEPliant Therapeutics to Participate in Upcoming Investor..
2024/2/0521:31EDGAR2Form 8-K - Current report
2024/2/0505:29GLOBEPliant Therapeutics Announces Positive Safety and..
2024/1/2506:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2506:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2506:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2506:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2007:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2007:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2007:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0322:00GLOBEPliant Therapeutics to Participate in the 42nd Annual J.P...
2023/11/1406:30GLOBEPliant Therapeutics Presentations at The Liver Meeting® 2023..
2023/11/1006:11EDGAR2Form 8-K - Current report
2023/11/1006:05GLOBEPliant Therapeutics Provides Corporate Update and Reports..
2023/11/0822:00GLOBEPliant Therapeutics to Participate in Upcoming Investor..
2023/11/0622:00GLOBEPliant Therapeutics Presentations at the Annual Meeting of..
2023/11/0105:03GLOBEPliant Therapeutics Announces Three Presentations at the..
2023/10/1921:00GLOBEPliant Therapeutics INTEGRIS-PSC Phase 2a Interim Data..
2023/10/1705:05GLOBEPliant Therapeutics Appoints S. Mishima Gerhart as Chief..
2023/10/0405:53EDGAR2Form 8-K - Current report
2023/9/2620:34EDGAR2Form 8-K - Current report
2023/9/2620:30GLOBEPliant Therapeutics Announces Positive Safety and..
2023/9/2605:05GLOBEPliant Therapeutics to Host Investor Call and Webcast to..
2023/9/1521:00GLOBEPliant Therapeutics Appoints Minnie Kuo as Chief Development..
2023/9/1121:00GLOBEPliant Therapeutics Announces Presentations at the European..
2023/8/3021:00GLOBEPliant Therapeutics to Participate in Upcoming Investor..
2023/8/2905:05GLOBEPliant Therapeutics Announces Three Upcoming Presentations..
2023/8/1005:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/1005:05EDGAR2Form 8-K - Current report
2023/8/1005:03GLOBEPliant Therapeutics Provides Corporate Update and Reports..
2023/8/0921:00GLOBEPliant Therapeutics Announces Initiation of BEACON-IPF, a..
2023/7/2521:00GLOBEPliant Therapeutics to Participate in Upcoming Investor..
2023/7/2205:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/2105:06EDGAR2Form 144 - Report of proposed sale of securities
2023/7/2009:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/2009:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..

最近閲覧した銘柄

Delayed Upgrade Clock